SEC Form 4 · accession 0001651308-18-000015
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Oyler
Officer — Chief Executive Officer · Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF5,F7,F1 | Dec 10, 2018 | S | 400 | $133.5725 | D | 3,738 | I | See Footnote |
| American Depositary SharesF5,F8,F1 | Dec 10, 2018 | S | 860 | $134.7409 | D | 2,878 | I | See Footnote |
| American Depositary SharesF5,F9,F1 | Dec 10, 2018 | S | 1,171 | $135.6974 | D | 1,707 | I | See Footnote |
| American Depositary SharesF5,F10,F1 | Dec 10, 2018 | S | 1,307 | $136.6497 | D | 400 | I | See Footnote |
| American Depositary SharesF5,F11,F1 | Dec 10, 2018 | S | 400 | $137.635 | D | 0 | I | See Footnote |
| Ordinary Shares | holding | — | — | — | 17,420,172 | D | ||
| Ordinary SharesF1 | holding | — | — | — | 29,439,115 | I | See Footnote | |
| Ordinary SharesF2 | holding | — | — | — | 10,000,000 | I | See Footnote | |
| Ordinary SharesF3 | holding | — | — | — | 102,188 | I | See Footnote | |
| Ordinary SharesF4 | holding | — | — | — | 7,952,787 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.30 to $137.2999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price.
- F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.33 to $138.3299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price.
- F2These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- F3These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
- F4These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F5Each American Depositary Share represents 13 Ordinary Shares.
- F6The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.00 to $133.9999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price.
- F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.12 to $135.1199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price.
- F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.28 to $136.2799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price.